These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 8084837)
1. Western blot assay for prostate-specific membrane antigen in serum of prostate cancer patients. Rochon YP; Horoszewicz JS; Boynton AL; Holmes EH; Barren RJ; Erickson SJ; Kenny GM; Murphy GP Prostate; 1994 Oct; 25(4):219-23. PubMed ID: 8084837 [TBL] [Abstract][Full Text] [Related]
2. Comparison of prostate specific antigen, prostate specific membrane antigen, and LNCaP-based enzyme-linked immunosorbent assays in prostatic cancer patients and patients with benign prostatic enlargement. Murphy GP; Holmes EH; Boynton AL; Kenny GM; Ostenson RC; Erickson SJ; Barren RJ Prostate; 1995 Mar; 26(3):164-8. PubMed ID: 7534919 [TBL] [Abstract][Full Text] [Related]
3. Measurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancer. Murphy GP; Kenny GM; Ragde H; Wolfert RL; Boynton AL; Holmes EH; Misrock SL; Bartsch G; Klocker H; Pointner J; Reissigl A; McLeod DG; Douglas T; Morgan T; Gilbaugh J Urology; 1998 May; 51(5A Suppl):89-97. PubMed ID: 9610563 [TBL] [Abstract][Full Text] [Related]
4. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Israeli RS; Miller WH; Su SL; Powell CT; Fair WR; Samadi DS; Huryk RF; DeBlasio A; Edwards ET; Wise GJ Cancer Res; 1994 Dec; 54(24):6306-10. PubMed ID: 7527294 [TBL] [Abstract][Full Text] [Related]
5. Combined nested RT-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in prostate cancer patients: correlation with pathological stage. Grasso YZ; Gupta MK; Levin HS; Zippe CD; Klein EA Cancer Res; 1998 Apr; 58(7):1456-9. PubMed ID: 9537248 [TBL] [Abstract][Full Text] [Related]
6. Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cells. Zhang Y; Zippe CD; Van Lente F; Klein EA; Gupta MK Clin Cancer Res; 1997 Jul; 3(7):1215-20. PubMed ID: 9815802 [TBL] [Abstract][Full Text] [Related]
7. Detection of circulating tumor cells in patients with prostate cancer using prostate specific membrane-derived primers in the polymerase chain reaction. Noguchi M; Miyajima J; Itoh K; Noda S Int J Urol; 1997 Jul; 4(4):374-9. PubMed ID: 9256327 [TBL] [Abstract][Full Text] [Related]
8. Expression of the prostate-specific membrane antigen. Israeli RS; Powell CT; Corr JG; Fair WR; Heston WD Cancer Res; 1994 Apr; 54(7):1807-11. PubMed ID: 7511053 [TBL] [Abstract][Full Text] [Related]
9. Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen. Cama C; Olsson CA; Raffo AJ; Perlman H; Buttyan R; O'Toole K; McMahon D; Benson MC; Katz AE J Urol; 1995 May; 153(5):1373-8. PubMed ID: 7536252 [TBL] [Abstract][Full Text] [Related]
10. Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids. Troyer JK; Beckett ML; Wright GL Int J Cancer; 1995 Sep; 62(5):552-8. PubMed ID: 7665226 [TBL] [Abstract][Full Text] [Related]
11. Prostate-specific membrane antigen and other prostatic tumor markers on the horizon. Israeli RS; Grob M; Fair WR Urol Clin North Am; 1997 May; 24(2):439-50. PubMed ID: 9126242 [TBL] [Abstract][Full Text] [Related]
12. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases. Bostwick DG; Pacelli A; Blute M; Roche P; Murphy GP Cancer; 1998 Jun; 82(11):2256-61. PubMed ID: 9610707 [TBL] [Abstract][Full Text] [Related]
13. Prostate-specific membrane antigen: current and future utility. Gregorakis AK; Holmes EH; Murphy GP Semin Urol Oncol; 1998 Feb; 16(1):2-12. PubMed ID: 9508077 [TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Horoszewicz JS; Kawinski E; Murphy GP Anticancer Res; 1987; 7(5B):927-35. PubMed ID: 2449118 [TBL] [Abstract][Full Text] [Related]
16. Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells. Pinto JT; Suffoletto BP; Berzin TM; Qiao CH; Lin S; Tong WP; May F; Mukherjee B; Heston WD Clin Cancer Res; 1996 Sep; 2(9):1445-51. PubMed ID: 9816319 [TBL] [Abstract][Full Text] [Related]
17. Detection of prostate-specific antigen- or prostate-specific membrane antigen-positive circulating cells in prostatic cancer patients: clinical implications. Millon R; Jacqmin D; Muller D; Guillot J; Eber M; Abecassis J Eur Urol; 1999 Oct; 36(4):278-85. PubMed ID: 10473985 [TBL] [Abstract][Full Text] [Related]
18. Prostate-specific membrane antigen levels in sera from healthy men and patients with benign prostate hyperplasia or prostate cancer. Beckett ML; Cazares LH; Vlahou A; Schellhammer PF; Wright GL Clin Cancer Res; 1999 Dec; 5(12):4034-40. PubMed ID: 10632336 [TBL] [Abstract][Full Text] [Related]
19. Evaluation and comparison of two new prostate carcinoma markers. Free-prostate specific antigen and prostate specific membrane antigen. Murphy GP; Barren RJ; Erickson SJ; Bowes VA; Wolfert RL; Bartsch G; Klocker H; Pointner J; Reissigl A; McLeod DG; Douglas T; Morgan T; Kenny GM; Ragde H; Boynton AL; Holmes EH Cancer; 1996 Aug; 78(4):809-18. PubMed ID: 8756376 [TBL] [Abstract][Full Text] [Related]
20. PSA-PSMA profiles and their impact on sera PSA levels and angiogenic activity in hyperplasia and human prostate cancer. Ben Jemaa A; Bouraoui Y; Sallami S; Banasr A; Nouira Y; Oueslati R Pathol Biol (Paris); 2014 Jun; 62(3):129-36. PubMed ID: 24745345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]